Combined effect of poverty and inflammation on mortality is worse than expected from separate effects, study reports

Researchers investigated whether the combination of chronic inflammation and poverty synergistically increases the 15-year risk of mortality from all causes, heart disease, and cancer in American adults aged 40 and older.

Silo Pharma Signs Agreement to Develop First-in-Class Ketamine Implant Therapeutic | Psychedelic Invest

Silo Pharma, Inc. (Nasdaq: SILO), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research, today announced its entry into a research and

June 14, 2023

Researchers develop peptide to target “chaotic” MYC protein in 75% of cancers

Meet MYC, the shapeless protein responsible for making the majority of human cancer cases worse.

January 4, 2024

Diet’s impact on gut bacteria offers new clues in Parkinson’s disease management

Researchers find that diet significantly influences the gut microbiome in Parkinson’s disease patients, potentially affecting disease progression and symptoms.

April 25, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.